Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3276817
Max Phase: Preclinical
Molecular Formula: C21H25N3O
Molecular Weight: 335.45
Molecule Type: Small molecule
Associated Items:
ID: ALA3276817
Max Phase: Preclinical
Molecular Formula: C21H25N3O
Molecular Weight: 335.45
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: O=C1c2ccccc2N(c2ccccc2)CCN1CCN1CCCC1
Standard InChI: InChI=1S/C21H25N3O/c25-21-19-10-4-5-11-20(19)24(18-8-2-1-3-9-18)17-16-23(21)15-14-22-12-6-7-13-22/h1-5,8-11H,6-7,12-17H2
Standard InChI Key: YFHLFXICDSSMQY-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 335.45 | Molecular Weight (Monoisotopic): 335.1998 | AlogP: 3.38 | #Rotatable Bonds: 4 |
Polar Surface Area: 26.79 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 0 |
#RO5 Violations: 0 | HBA (Lipinski): 4 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 8.41 | CX LogP: 3.19 | CX LogD: 2.14 |
Aromatic Rings: 2 | Heavy Atoms: 25 | QED Weighted: 0.86 | Np Likeness Score: -1.09 |
1. Bagolini C, de Witt P, Pacifici L, Ramacci MT.. (1978) Synthesis and pharmacological activity and some derivatives of 1-phenyl-1,2,3,4-tetrahydro-5H-1,4-benzodiazepin-5-one., 21 (5): [PMID:26804] [10.1021/jm00203a015] |
Source(1):